Page 558 - IJB-10-3
P. 558

International Journal of Bioprinting                               Engineered 3D-printed PVA vascular grafts
























































            Figure 13. Biocompatibility assessment of the modified vascular graft using the extract method for bEnd.3 endothelial cells, L929 fibroblasts, and U937
            monocyte-like cells. (A) Viability of cells following a 24-h incubation with the vascular graft extract (via MTT assay). Data presented as mean ± standard
            deviation; **p < 0.01. (B) Adenosine triphosphate (ATP) content in cells following a 24-h incubation with the vascular graft extract (via ATP assay). Data
            presented as mean ± standard deviation; **p < 0.01. (C) Levels of lactate dehydrogenase (LDH) released from cells following a 24-h incubation with the
            vascular graft extract (via LDH assay). Data presented as mean ± standard deviation; *p < 0.05. (D–I) Cell morphology following a 24-h incubation with
            the vascular graft extract: (D–F) negative controls (NC) and (G–I) 1:1 graft extract; (D and G) bEnd.3 endothelial cells, (E and H) L929 fibroblasts, and (F
            and I) U937 monocyte cells. Magnification: ×10.


            the endothelial cells’ metabolism at 24 h was similar to   to the negative control (Figure 15A–C). These findings
            the  graft’s extract, leading to  a slight inhibition  within   suggest that the modification of the vascular graft
            the  biocompatibility  limits  (ISO  10993-5)  (Figure   using lysine improved the material compatibility for
            14A,  B,  and  D–G). However, a small amount of LDH   endothelial cells  in vitro,  indicating biocompatibility
            was released from the cells due to contact with the   according to ISO-10993-5 and maintenance of the cells’
            modified vascular graft (0.27 ± 0.033% compared to   normal morphology.
            the negative control;  p < 0.05) (Figure 14C). At 72 h,   At 24 h, the modified vascular graft had no significant
            the effect of the vascular graft on bEnd.3 metabolism   effect on the L929 fibroblast cells’ metabolism (compared
            was maintained under the same biocompatibility limits.   to negative control) (Figure 14A and B). A small amount
            However, no extracellular LDH was measured compared   of LDH was measured in the extracellular environment of


            Volume 10 Issue 3 (2024)                       550                                doi: 10.36922/ijb.2193
   553   554   555   556   557   558   559   560   561   562   563